Currently predicting for Thu, 4 Jun 2026

ACRS Prediction Chart

ACRS Predictions History

Latest community submissions for ACRS.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Apr 5, 2021 $27.31 -2.64% $28.05 X 97.36% 1
Apr 5, 2021 Bearish $28.05 X 0
jjsheets330 jjsheets330 Merchant @jjsheets330.186247
Mar 23, 2021 $28.00 +10.54% $25.33 X 89.46% 0
JS JS Pro
Mar 23, 2021 $26.66 +5.25% $25.33 X 94.75% 1
Mar 23, 2021 Bullish $25.33 X 0
JS JS Pro
Jul 8, 2020 $1.74 +0.00% $1.74 X 100.00% 10
JS JS Pro
Nov 11, 2019 $2.02 +6.88% $1.89 X 93.12% 0
Cory Hutting Cory Hutting @CoryHutting.124991
Nov 11, 2019 $1.95 +3.17% $1.89 X 96.83% 1
Nov 4, 2019 $1.90 +4.97% $1.81 X 95.03% 0
JS JS Pro
Nov 4, 2019 $1.85 +2.21% $1.81 X 97.79% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ACRS with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ACLARIS THERAPEUTICS
Aclaris Therapeutics
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment engages in the provision of...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE